The Quantellect read.As of Nov 19, 2026, 12 active firms cover Omega Healthcare Investors Inc: 4 rate it Buy or better, 6 sit at Neutral, and 2 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $45.00 to $58.00, so the covering firms are broadly aligned. The average target of $49.00 sits 4% above the current $47.08. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.50 next quarter toward $2.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 active firms
Neutral
Strong Buy00%
Buy433%
Neutral650%
Sell217%
Strong Sell00%
Based on 12 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$49.00
+4.1% upside
Average target across 12 active firms as of Nov 19, 2026 vs $47.08 current
Highest Target$58.00
Average Target$49.00
Lowest Target$45.00
Detailed analyst forecasts for OHI
Showing 1–14 of 14 named analysts shown · 12 active firms in the rating projection
As of Nov 19, 2026, 4 of 12 active firms rate OHI a Buy (6 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
OHI EPS & revenue forecast
EPS · NEXT QUARTER
$0.50
Range $0.46 – $0.53 · 3 analysts · +6% YoY
Next period, 3 analysts expect Omega Healthcare Investors Inc to earn $0.50 a share (range $0.46 – $0.53), versus $0.48 a year earlier. Full-year consensus is $2.67, growing to $2.08 the year after.
REVENUE · NEXT QUARTER
$296.4M
Range $267.0M – $337.4M · 3 analysts · +11% YoY
Revenue is expected to reach $296.4M (range $267.0M – $337.4M), +11.1% year-over-year. Full-year consensus is $1.1B, rising to $1.2B next year.
Top analysts covering Omega Healthcare Investors Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OHI.
#1
Jonathan Hughes
Raymond James · Rank #42
Buy
$46.00-2.3% to target
Overall win rate
52%
+ Follow
#2
Nicholas Yulico
Scotiabank · Rank #77
Neutral
$50.00+6.2% to target
Overall win rate
53%
+ Follow
#3
John Kilichowski
Wells Fargo · Rank #103
Neutral
$48.00+2.0% to target
Overall win rate
50%
+ Follow
#4
Richard Hightower
Barclays · Rank #184
Sell
$48.00+2.0% to target
Overall win rate
45%
+ Follow
#5
Michael Lewis
Truist Securities · Rank #243
Neutral
$47.00-0.2% to target
Overall win rate
43%
+ Follow
OHI stock forecast FAQ
What is OHI's average 12-month price target?+
The 12 active firms with a live target average $49.00 for Omega Healthcare Investors Inc over the next 12 months, ranging from a $58.00 high to a $45.00 low, as of Nov 19, 2026.
Is OHI stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 12 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 6 rate it Neutral, and 2 rate it Sell or Strong Sell.
What are the highest and lowest price targets for OHI?+
The Street-high target is $58.00 (Citigroup), and the Street-low is $45.00 (BMO Capital). The average of all 12 active-firm targets is $49.00.
How many active Wall Street firms cover OHI?+
12 active firms have a recognized rating on Omega Healthcare Investors Inc as of Nov 19, 2026, and 12 active firms carry a live 12-month price target.
Who is the most accurate analyst covering OHI?+
Among analysts who currently cover OHI, Jonathan Hughes of Raymond James has the strongest overall Quantellect track record (Rank #42). Their current call is Buy with a $46.00 target.
What is Omega Healthcare Investors Inc's projected EPS for next quarter?+
The consensus estimate is $0.50 per share (range $0.46 – $0.53) across 3 analysts. Full-year EPS is projected at $2.67, rising to $2.08 the following year.
How much revenue is Omega Healthcare Investors Inc expected to report next quarter?+
Consensus revenue is $296.4M (range $267.0M – $337.4M). Full-year revenue is projected at $1.1B, growing to $1.2B next year.
Have analysts been upgrading or downgrading OHI lately?+
As of Nov 19, 2026, 4 of 12 active firms rate OHI a Buy (6 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OHI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.